Post-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for the Prevention of Chronic or Episodic Migraine
Clinical trial NCT06603558 · RECRUITING
Trial details
- NCT number
- NCT06603558
- Sponsor
- AbbVie
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-09-24
- Primary completion
- 2029-05-01
- Enrollment
- 3000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.